1. Home
  2. FULC vs KELYB Comparison

FULC vs KELYB Comparison

Compare FULC & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • KELYB
  • Stock Information
  • Founded
  • FULC 2015
  • KELYB 1946
  • Country
  • FULC United States
  • KELYB United States
  • Employees
  • FULC N/A
  • KELYB N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • KELYB Professional Services
  • Sector
  • FULC Health Care
  • KELYB Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • KELYB Nasdaq
  • Market Cap
  • FULC 469.0M
  • KELYB 389.9M
  • IPO Year
  • FULC 2019
  • KELYB N/A
  • Fundamental
  • Price
  • FULC $7.87
  • KELYB $11.06
  • Analyst Decision
  • FULC Buy
  • KELYB
  • Analyst Count
  • FULC 7
  • KELYB 0
  • Target Price
  • FULC $10.43
  • KELYB N/A
  • AVG Volume (30 Days)
  • FULC 618.0K
  • KELYB 201.0
  • Earning Date
  • FULC 10-29-2025
  • KELYB 11-06-2025
  • Dividend Yield
  • FULC N/A
  • KELYB 2.55%
  • EPS Growth
  • FULC N/A
  • KELYB N/A
  • EPS
  • FULC N/A
  • KELYB N/A
  • Revenue
  • FULC N/A
  • KELYB $4,495,900,000.00
  • Revenue This Year
  • FULC N/A
  • KELYB $4.55
  • Revenue Next Year
  • FULC N/A
  • KELYB $5.01
  • P/E Ratio
  • FULC N/A
  • KELYB N/A
  • Revenue Growth
  • FULC 2752.05
  • KELYB 0.97
  • 52 Week Low
  • FULC $2.32
  • KELYB $11.04
  • 52 Week High
  • FULC $10.11
  • KELYB $19.82
  • Technical
  • Relative Strength Index (RSI)
  • FULC 40.58
  • KELYB 36.66
  • Support Level
  • FULC $8.42
  • KELYB $12.96
  • Resistance Level
  • FULC $9.47
  • KELYB $13.47
  • Average True Range (ATR)
  • FULC 0.80
  • KELYB 0.04
  • MACD
  • FULC -0.21
  • KELYB -0.34
  • Stochastic Oscillator
  • FULC 7.11
  • KELYB 0.00

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: